RxDoctor Payments DataLook up a doctor →

Daniel Catenacci

Internal Medicine · Chicago, ILNPI 1467609537

Payments from drug & device makers

$3,490,710in general payments, 2019–2025

Across 457 payments — averaging $7638.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$1.5M
  • Seagen Inc.$514K
  • Astrazeneca UK Limited$369K
  • Incyte Corporation$307K
  • E.r. Squibb & Sons, L.L.C.$199K
  • AstraZeneca$181K
  • plus $464K from 18 others

What the payments were for

  • Consulting fees$94,93659%
  • Speaking & faculty fees$60,06037%
  • Travel & lodging$4,2623%
  • Food & beverage$1,7851%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,490,710 in reported general payments places this provider in the 95th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois

Other internal medicine in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →